Use App
AI Agent
Trending
News
Earnings
All
DIA
0.35%
SPY
0.24%
QQQ
1.26%
Trending
INTC
5.42%
SNDK
8.98%
BTC
3.10%
MU
6.19%
NVDA
2.46%
SOXL
12.28%
MRVL
6.35%
ONDS
1.93%
KORU
19.61%
CBRS
12.41%
Feed
News
Sentiment
Fundamentals
Info
home
Symbol
GRI
news
Exchange:
NASDAQ
·
Updated 07:30 PM EDT
GRI News
News
all
press releases
GRI Bio, Inc. (GRI) Upgraded to Buy: What Does It Mean for the Stock?
GRI Bio, Inc. (GRI) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Zacks
GRI Bio Reports Positive Study Results For Chronic Lung Disease, But Stock Slumps 20% — What Happened?
The company said that the new data indicate that GRI-0621 may support the regeneration of lung tissue.
Stocktwits
Full Article
GRI Bio Drug Shows Promising Lung Function Recovery In Patients With Thickened Lungs
GRI Bio shared promising data from a Phase 2a trial for idiopathic pulmonary fibrosis, a chronic lung disease with no known cause.read more...
Benzinga
Barclays lifts Kojamo, I-RES ratings; cuts Grainger on low yield
investing.com
1
Advertisement
|
Remove ads.
Home
Watchlist
Trending
News
Explore
Profile